Who founded Genomill?

Genomill was founded by Manu Tamminen, Sami Savisalo, Juuso Blomster, Jukka Laine in 2016.

Who are Genomill's investors?

Genomill's investors include Voima Ventures.

Where is Genomill headquartered?

Genomill is headquartered in Turku, FI.

Genomill

Turku, FI · Founded 2016 · 12 employees on LinkedIn · 1 known investors

Find your way into Genomill

585 people in our graph share verified history with the Genomill team — schools, employers, funds. One of them is your warm intro.

Ville Heikkinenunlockedknows Sami Savisalo · together at Fondia Oyj (overlapped)

knows the team · via Fondia Oyj

knows the team · via Liveto

×2knows the team · via Genomill

×3knows the team · via Precordior Ltd

×4knows the team · via AstraZeneca

GenomILL develops precision diagnostic technologies using genomic analysis. The company serves clinical and research customers seeking advanced molecular diagnostics.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Genomill was founded in 2016 by Manu Tamminen, Sami Savisalo, Juuso Blomster, and Jukka Laine.

Manu Tamminen CEO, Co-FounderManu Tamminen is a molecular biologist with expertise in next-generation DNA sequencing platforms. He is co-founder and CEO of Genomill, which develops precision diagnostic technologies using genomic analysis.

Sami Savisalo Chair of the Board, Co-founderSami Savisalo is a business lawyer with two decades of experience in legal matters for Finnish growth companies and listed entities, with specialization in venture capital, mergers and acquisitions, and intellectual property across healthcare, biotech, and deep tech sectors. He is chair of the board and co-founder of Genomill, which develops precision diagnostic technologies using genomic analysis.

Juuso Blomster Board Member, Co-FounderJuuso Blomster holds an MD and PhD and trained as a cardiologist before co-founding Genomill, which develops precision diagnostic technologies using genomic analysis.

Jukka Laine Medical Advisor, Co-FounderJukka Laine is a pathology researcher and physician who trained under Prof. Timo Nevalainen studying inflammatory and antibacterial signaling, later focusing on genetics in neonatal disease and cancer susceptibility. He holds a position as Docent in experimental pathology and pediatric pathology specialist at Turku University Hospital, has published over 80 peer-reviewed scientific papers, and co-founded Modern Diagnostics and Genomill Health to develop NGS-based diagnostic technologies for cancer monitoring and hereditary disease detection.

Investors · 1

Voima Ventureslisted by Voima VenturesHelsinki · $216K – $3.2M

How we know: Voima Ventures's portfolio page · funding news · press coverage · Not right? Tell us

Frequently asked questions

What does Genomill do?: GenomILL develops precision diagnostic technologies using genomic analysis. The company serves clinical and research customers seeking advanced molecular diagnostics.
Who founded Genomill?: Genomill was founded by Manu Tamminen, Sami Savisalo, Juuso Blomster, Jukka Laine in 2016.
Who are Genomill's investors?: Genomill's investors include Voima Ventures.
Where is Genomill headquartered?: Genomill is headquartered in Turku, FI.